Citius Pharmaceuticals, Inc. 10-Q, filed Feb 13, 2020: IDEA: XBRL DOCUMENT
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($) |
1 Months Ended | ||
|---|---|---|---|
Mar. 30, 2016 |
Dec. 31, 2019 |
Oct. 02, 2019 |
|
| Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual) | |||
| Right of use asset and lease liability | $ 1,122,442 | ||
| Operating Lease Arrangement [Member] | |||
| Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual) | |||
| Right of use asset and lease liability | $ 1,137,724 | ||
| Series of Individually Immaterial Business Acquisitions [Member] | |||
| Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual) | |||
| Intangible assets | $ 19,400,000 | ||
| Goodwill | $ 1,586,796 | ||
| Amortized on straight-line basis period | 8 years |